Efficacy and Safety of RAdiofrequency Versus HAL- RAR DOppler in Hemorrhoidal Pathology

Launched by ELSAN · May 20, 2021

Keywords

ClinConnect Summary

This clinical trial is studying two different techniques for treating hemorrhoids, a common condition that can cause pain, bleeding, and discomfort. The trial compares the effectiveness and safety of a newer method called radiofrequency treatment (Rafaelo technique) to a traditional method called HAL-RAR (a type of surgical procedure). The aim is to see which method works better and helps patients recover more quickly, with less pain and time off from work.

To participate in this trial, individuals must be between 18 and 75 years old and have hemorrhoids that have not responded to other treatments. They should not have certain health conditions, such as inflammatory bowel disease or anal fistulas. Participants can expect a minimally invasive procedure, which means they may experience less pain and a quicker return to their daily activities. This study is particularly important because it aims to gather information about the new radiofrequency technique, which has not been evaluated in France yet, helping to improve treatment options for people suffering from hemorrhoids.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or Female consulting for hemorrhoidal pathology (grade II or III) after failure of medico-instrumental treatments.
• • Age ≥ 18 years and \< 75 years
• • Mandatory affiliation to a health insurance system.
• • Patient having been informed of the study and having given informed consent
• Exclusion Criteria:
• • Patients with chronic inflammatory bowel disease
• • Patients with suspected gastro-colic pathology
• • Haematological diseases
• • Anal fistulas
• • Patients unable to discontinue anti-vitamin K or oral anticoagulants
• • Associated anal fissure
• • External haemorrhoidal disease
• • Pregnant or breastfeeding women
• • Patients under legal protection